BJDX vs WELL · $5.0M cap vs P/E 100, rev $10.84B
Bluejay Diagnostics Inc (BJDX) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
BJDX does not have a complete income-statement cache yet.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
BJDX currently screens at market cap $5.0M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the BJDX and WELL stock pages for the full models.
Not investment advice.